Canada Pension Plan Investment Board
XERS icon

Canada Pension Plan Investment Board’s Xeris Biopharma Holdings XERS Stock Holding History

Canada Pension Plan Investment Board’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Sell
219,200
-155,600
-42% -$994K ﹤0.01% 925
2026
Q1 		$2.17M Sell
374,800
-15,800
-4% -$105K ﹤0.01% 895
2025
Q4 		$3.07M Buy
390,600
+14,900
+4% +$117K ﹤0.01% 868
2025
Q3 		$3.06M Buy
+375,700
New +$2.5M ﹤0.01% 836

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Canada Pension Plan Investment Board's XERS Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Xeris Biopharma Holdings (XERS) stake by 42% in Q2 2026, selling an estimated $994K and leaving 219,200 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #925.

Canada Pension Plan Investment Board first reported a position in XERS in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.07M in Q4 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Canada Pension Plan Investment Board held 219,200 shares of Xeris Biopharma Holdings worth $1.74M as of Q2 2026.
  • Canada Pension Plan Investment Board sold 155,600 Xeris Biopharma Holdings shares in Q2 2026, an estimated $994K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #925 holding.
  • Canada Pension Plan Investment Board first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 4 quarters since.
  • Canada Pension Plan Investment Board's Xeris Biopharma Holdings position peaked at $3.07M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.